These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Design of conformationally constrained angiotensin-converting enzyme inhibitors. Weller HN; Gordon EM; Rom MB; Pluscec J Biochem Biophys Res Commun; 1984 Nov; 125(1):82-9. PubMed ID: 6095846 [TBL] [Abstract][Full Text] [Related]
12. Effect of a new angiotensin converting enzyme inhibitor MK 421 and its lysine analogue on the components of the renin system in healthy subjects. Brunner DB; Desponds G; Biollaz J; Keller I; Ferber F; Gavras H; Brunner HR; Schelling JL Br J Clin Pharmacol; 1981 May; 11(5):461-7. PubMed ID: 6268131 [TBL] [Abstract][Full Text] [Related]
13. Cyclic (hydroxyphosphinyl)acyl dipeptides: a new class of angiotensin converting enzyme inhibitors. Weller HN; Rom MB J Enzyme Inhib; 1988; 2(3):183-98. PubMed ID: 3071574 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of angiotensin I-converting enzyme with S 9490: biochemical effects, interspecies differences, and role of sodium diet in hemodynamic effects. Laubie M; Schiavi P; Vincent M; Schmitt H J Cardiovasc Pharmacol; 1984; 6(6):1076-82. PubMed ID: 6084763 [TBL] [Abstract][Full Text] [Related]
15. CI-906 and CI-907: new orally active nonsulfhydryl angiotensin-converting enzyme inhibitors. Kaplan HR; Cohen DM; Essenburg AD; Major TC; Mertz TE; Ryan MJ Fed Proc; 1984 Apr; 43(5):1326-9. PubMed ID: 6323223 [TBL] [Abstract][Full Text] [Related]
16. Antihypertensive therapy with MK 421: angiotensin II--renin relationships to evaluate efficacy of converting enzyme blockade. Biollaz J; Brunner HR; Gavras I; Waeber B; Gavras H J Cardiovasc Pharmacol; 1982; 4(6):966-72. PubMed ID: 6185790 [TBL] [Abstract][Full Text] [Related]